Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Other financing activities (2021 - 2025)

Edgewise Therapeutics has reported Other financing activities over the past 5 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Other financing activities at $5.9 million for Q4 2025, down 36.3% from a year ago — trailing twelve months through Dec 2025 was $7.8 million (down 28.49% YoY), and the annual figure for FY2025 was $7.8 million, down 17.69%.
  • Other financing activities reached $5.9 million in Q4 2025 per EWTX's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $9.2 million in Q4 2024 and bottomed at -$97000.0 in Q4 2023.
  • Median Other financing activities over the past 5 years was $169000.0 (2021), compared with a mean of $1.6 million.
  • The largest annual shift saw Other financing activities surged 9603.09% in 2024 before it crashed 85.23% in 2025.
  • Over 5 years, Other financing activities stood at $124000.0 in 2021, then plummeted by 168.55% to -$85000.0 in 2022, then decreased by 14.12% to -$97000.0 in 2023, then soared by 9603.09% to $9.2 million in 2024, then crashed by 36.3% to $5.9 million in 2025.
  • Business Quant data shows Other financing activities for EWTX at $5.9 million in Q4 2025, $1.7 million in Q3 2025, and $233000.0 in Q2 2025.